News

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.
Arkansas will receive $44.5 million annually for 17 years as part of a settlement with Purdue Pharma and the Sackler family, with one-third of the funds allocated to the state and the remaining ...
A member of the Sackler family, which owns OxyContin-maker Purdue Pharma, expressed "sadness" over the nation's opioid epidemic during a congressional hearing Thursday that marked the first time ...
Purdue Pharma’s $7B opioid settlement could advance after states back it The deal calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 ...
Purdue Pharma’s $7B opioid settlement plan could get votes from victims and cities Members of the Sackler family who own the company would pay up to $7 billion and give up ownership on the company.
A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, was agreed to be signed by 55 attorneys general representing states and United States territories, Attorney General ...
Purdue Pharma begins vote on $7.4 bln opioid settlement By Dietrich Knauth June 20, 20252:51 PM PDTUpdated June 20, 2025 ...
Under the plan, the Sackler family members would give up ownership of Purdue. They resigned from the company’s board and stopped receiving distributions from its funds before the company’s ...
COVENTRY, R.I. (AP) — A Connecticut court has ordered a member of the family that owns Purdue Pharma to testify in Rhode Island’s lawsuit against the drug maker over its role in the national opioid ...
Arkansas will receive $44.5 million annually for 17 years as part of a settlement with Purdue Pharma and the Sackler family, with one-third of the funds allocated to the state and the remaining ...
Under the plan, the Sackler family members would give up ownership of Purdue. They resigned from the company’s board and stopped receiving distributions from its funds before the company’s ...